Offc Action Outgoing

TEVA

Teva Pharmaceutical Industries Limited

U.S. Trademark Application Serial No. 88749354 - TEVA - N/A

To: Teva Pharmaceutical Industries Limited (trademarks.trademarks@tevapharm.com)
Subject: U.S. Trademark Application Serial No. 88749354 - TEVA - N/A
Sent: December 23, 2020 01:52:14 PM
Sent As: ecom128@uspto.gov
Attachments:

United States Patent and Trademark Office (USPTO)

Office Action (Official Letter) About Applicant’s Trademark Application

 

U.S. Application Serial No. 88749354

 

Mark:  TEVA

 

 

 

 

Correspondence Address: 

Laurence Rickles

TEVA PHARMACEUTICALS USA, INC.

400 INTERPACE PARKWAY

PARSIPPANY NJ 07054

 

 

 

Applicant:  Teva Pharmaceutical Industries Limited

 

 

 

Reference/Docket No. N/A

 

Correspondence Email Address: 

 trademarks.trademarks@tevapharm.com

 

 

 

FINAL OFFICE ACTION

 

The USPTO must receive applicant’s response to this letter within six months of the issue date below or the application will be abandoned.  Respond using the Trademark Electronic Application System (TEAS) and/or Electronic System for Trademark Trials and Appeals (ESTTA).  A link to the appropriate TEAS response form and/or to ESTTA for an appeal appears at the end of this Office action. 

 

 

Issue date:  December 23, 2020

 

INTRODUCTION

 

This Office action is in response to applicant’s communication filed on November 11, 2020.

 

In a previous Office action(s) dated October 26, 2020, the trademark examining attorney refused registration of the applied-for mark based on the following: failure to show the applied-for mark in use in commerce with any of the specified goods. 

 

Further, the trademark examining attorney maintains and now makes FINAL the refusal in the summary of issues below.  See 37 C.F.R. §2.63(b); TMEP §714.04.

 

SUMMARY OF ISSUES MADE FINAL that applicant must address:

  • Specimen Refusal

 

SPECIMEN REFUSAL

 

In the October 26, 2020 Office action, the specimen was refused because it failed to show the mark used in commerce in association with the identified goods.  Applicant submitted arguments in response to this refusal, which are unpersuasive for the reasons discussed immediately below.  Accordingly, the specimen refusal is hereby made FINAL.

 

Material used only to conduct internal business is not an acceptable specimen.  Registration is refused because the specimen is merely material used by applicant to conduct its internal business and does not show the applied-for mark as actually used in commerce for International Class(es) 1.  Trademark Act Sections 1 and 45, 15 U.S.C. §§1051, 1127; 37 C.F.R. §§2.34(a)(1)(iv), 2.56(a); TMEP §§904, 904.04(b), 904.07(a).  An application based on Trademark Act Section 1(a) must include a specimen showing the applied-for mark as actually used in commerce for each international class of goods identified in the statement of use.  15 U.S.C. §1051(a)(1); 37 C.F.R. §§2.34(a)(1)(iv), 2.56(a); TMEP §§904, 904.07(a). 

 

Material used by an applicant only to conduct its internal business is not an acceptable specimen for goods.  See 37 C.F.R. §2.56(a); In re Chi. Rawhide Mfg. Co., 455 F.2d 563, 565, 173 USPQ 8, 9 (C.C.P.A. 1972); In re Bright of Am., Inc., 205 USPQ 63, 71 (TTAB 1979); TMEP §904.04(b).  “These materials include all documents whose sole function is to carry out the applicant’s business dealings, such as invoices, bill heads, waybills, warranties, and business stationery.”  TMEP §904.04(b); see e.g., In re Chi. Rawhide Mfg. Co., 455 F.2d at 565, 173 USPQ at 9; In re Bright of Am., Inc., 205 USPQ at 65.

 

Specifically, the specimen consists of an invoice for the goods, which, as discussed above, is considered to be an internal business document because its sole purpose is to carry out the applicant’s business dealings.  In applicant’s October 26, 2020 response, applicant argues that the invoice is not an internal business document because the invoice is addressed to a third-party.  However, as the discussion above shows, invoices, even those directed to third-parties, serve the sole function of carrying out the applicant’s business activities.  Therefore, generally, invoices are unacceptable as specimens for goods.

 

Applicant should note that invoices may be acceptable as a specimen for goods in the situation where it is impracticable to place the mark on the goods.  Such situation may be found when goods such as natural gas or grain are sold in bulk or when chemicals are only transported in tanker cars.  TMEP §904.03(k).  However, the mere assertion of impracticability is not sufficient to show that it is impracticable to place the mark on goods.  Id.  Applicant must establish for the record that the goods are of such nature.  Id.

 

Examples of specimens.  Specimens for goods include a photograph of (1) the actual goods bearing the mark; (2) an actual container, packaging, tag or label for the goods bearing the mark; or (3) a point-of-sale display showing the mark directly associated with the goods.  See 37 C.F.R. §2.56(b)(1), (c); TMEP §904.03(a)-(m).  A webpage specimen submitted as a display associated with the goods must show the mark in association with a picture or textual description of the goods and include information necessary for ordering the goods.  TMEP §904.03(i); see 37 C.F.R. §2.56(b)(1), (c).  Any webpage printout or screenshot submitted as a specimen must include the webpage’s URL and the date it was accessed or printed on the specimen itself, within the TEAS form that submits the specimen, or in a verified statement under 37 C.F.R. §2.20 or 28 U.S.C. §1746 in a later-filed response.  See 37 C.F.R. §2.56(c); TMEP §§904.03(i), 1301.04(a).

 

Response option.  Applicant may respond to this refusal by submitting, for each applicable international class, a different specimen (a verified “substitute” specimen) that (a) was in actual use in commerce prior to the expiration of the deadline for filing the statement of use and (b) shows the mark in actual use in commerce for the goods identified in the statement of use.  A “verified substitute specimen” is a specimen that is accompanied by the following statement made in a signed affidavit or supported by a declaration under 37 C.F.R. §2.20:  “The substitute (or new, or originally submitted, if appropriate) specimen(s) was/were in use in commerce prior to expiration of the filing deadline for filing a statement of use.”  The substitute specimen cannot be accepted without this statement.

 

Applicant may not withdraw the statement of use.  See 37 C.F.R. §2.88(f); TMEP §1109.17.

 

For an overview of this response option and instructions on how to submit a different specimen using the online Trademark Electronic Application System (TEAS) form, see the Specimen webpage.

 

ASSISTANCE

 

Please call or email the assigned trademark examining attorney with questions about this Office action.  Although an examining attorney cannot provide legal advice, the examining attorney can provide additional explanation about the refusal(s) and/or requirement(s) in this Office action.  See TMEP §§705.02, 709.06. 

 

The USPTO does not accept emails as responses to Office actions; however, emails can be used for informal communications and are included in the application record.  See 37 C.F.R. §§2.62(c), 2.191; TMEP §§304.01-.02, 709.04-.05. 

 

How to respond.  Click to file a request for reconsideration of this final Office action that fully resolves all outstanding requirements and refusals and/or click to file a timely appeal to the Trademark Trial and Appeal Board (TTAB) with the required filing fee(s).

 

 

/Bridget Watson/

Bridget Watson

Examining Attorney

Law Office 128

(571) 272-7163

bridget.watson@uspto.gov

 

 

 

RESPONSE GUIDANCE

  • Missing the response deadline to this letter will cause the application to abandon.  A response or notice of appeal must be received by the USPTO before midnight Eastern Time of the last day of the response period.  TEAS and ESTTA maintenance or unforeseen circumstances could affect an applicant’s ability to timely respond.  

 

 

 

U.S. Trademark Application Serial No. 88749354 - TEVA - N/A

To: Teva Pharmaceutical Industries Limited (trademarks.trademarks@tevapharm.com)
Subject: U.S. Trademark Application Serial No. 88749354 - TEVA - N/A
Sent: December 23, 2020 01:52:15 PM
Sent As: ecom128@uspto.gov
Attachments:

United States Patent and Trademark Office (USPTO)

 

USPTO OFFICIAL NOTICE

 

Office Action (Official Letter) has issued

on December 23, 2020 for

U.S. Trademark Application Serial No. 88749354

 

Your trademark application has been reviewed by a trademark examining attorney.  As part of that review, the assigned attorney has issued an official letter that you must respond to by the specified deadline or your application will be abandoned.  Please follow the steps below.

 

(1)  Read the official letter.

 

(2)  Direct questions about the contents of the Office action to the assigned attorney below. 

 

 

/Bridget Watson/

Bridget Watson

Examining Attorney

Law Office 128

(571) 272-7163

bridget.watson@uspto.gov

 

 

Direct questions about navigating USPTO electronic forms, the USPTO website, the application process, the status of your application, and/or whether there are outstanding deadlines or documents related to your file to the Trademark Assistance Center (TAC).

 

(3)  Respond within 6 months (or earlier, if required in the Office action) from December 23, 2020, using the Trademark Electronic Application System (TEAS).  The response must be received by the USPTO before midnight Eastern Time of the last day of the response period.  See the Office action for more information about how to respond

 

 

 

GENERAL GUIDANCE

·         Check the status of your application periodically in the Trademark Status & Document Retrieval (TSDR) database to avoid missing critical deadlines.

 

·         Update your correspondence email address, if needed, to ensure you receive important USPTO notices about your application.

 

·         Beware of misleading notices sent by private companies about your application.  Private companies not associated with the USPTO use public information available in trademark registrations to mail and email trademark-related offers and notices – most of which require fees.  All official USPTO correspondence will only be emailed from the domain “@uspto.gov.”

 

 

 


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed